View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's Ratings assigns Baa3 rating to CVS' sr. notes; stable outlook

Moody's Ratings (Moody's) assigned a Baa3 rating to the new senior unsecured notes issuance of CVS Health Corporation ("CVS"). There are no changes to CVS's existing ratings including the Baa3 senior unsecured notes, (P) Baa3 senior unsecured shelf, Ba1 junior subordinated notes, and Prime-3 commerc...

CVS Health Corp: 1 director

A director at CVS Health Corp sold 3,750,000 shares at 67.652USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

 PRESS RELEASE

EQS-News: Wechsel im Vorstand der Tochtergesellschaft DocCheck agency ...

EQS-News: DocCheck AG / Schlagwort(e): Sonstiges Wechsel im Vorstand der Tochtergesellschaft DocCheck agency ag - Thilo Kölzer übernimmt Aufgaben von Christiane Schrix 27.02.2025 / 18:02 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die Vorständin Christiane Schrix hat heute den Aufsichtsrat der DocCheck agency ag informiert, dass sie ihr bis zum 31.03.2027 laufendes Vorstandsmandat und die damit verbundenen Ämter vorzeitig niederlegen möchte, um sich einer neuen Aufgabe zu widmen. Der Vorstand der DocCheck AG und der Aufsichtsrat ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 22, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

CVS Health Corporation: Update to credit analysis following downgrade ...

Our credit view of this issuer reflects its execution risk related to expansion into primary care and its regulatory uncertainty related to PBM and pharmacy business practices.

Moody's Ratings downgrades CVS Health to Baa3; outlook stable

Moody's Ratings (Moody's) downgraded the ratings of CVS Health Corporation (CVS) including the senior unsecured notes to Baa3 from Baa2; the senior unsecured shelf to (P)Baa3 from (P)Baa2, the junior subordinated notes to Ba1 from Baa3 and the senior unsecured commercial paper rating to Prime-3 from...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Moody's Ratings assigns Baa3 rating to CVS' jr. subordinated notes, on...

Moody's Ratings (Moody's) assigned a Baa3 rating to CVS Health Corporation's (CVS) proposed offering of junior subordinated notes, with this rating immediately placed on review for downgrade. There are no changes to CVS' existing ratings including the Baa2 senior unsecured notes, (P)Baa2 senior unse...

 PRESS RELEASE

EQS-News: Vorläufige Neunmonatszahlen

EQS-News: DocCheck AG / Schlagwort(e): 9-Monatszahlen Vorläufige Neunmonatszahlen 04.11.2024 / 18:52 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die DocCheck Gruppe (ISIN DE000A1A6WE6) gibt heute vorläufige Neunmonatszahlen für das Geschäftsjahr 2024 bekannt. In den ersten neun Monaten des Jahres 2024 erwirtschaftete die DocCheck Gruppe einen Umsatz von 37,5 Millionen Euro (Vorjahr: 39,4 Millionen Euro). Dabei wurde ein EBIT von 3,5 bis 3,7 Millionen Euro erzielt (Vorjahr: 3,5 Millionen Euro). An der in der Meldung vom 06. August ...

CVS Health Corporation: Update following ratings under review for down...

Our credit view of this issuer reflects good scale and diversity, tempered by cost pressures in the Medicare Advantage business.

Moody's Ratings reviews CVS's ratings for downgrade

Moody's Ratings (Moody's) placed the ratings of CVS Health Corporation (CVS) on review for downgrade. The ratings placed on review include the Baa2 senior unsecured notes, (P)Baa2 senior unsecured shelf and Prime-2 senior unsecured commercial paper rating. Previously, the outlook was negative. The...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

CVS Health Corporation: Update to credit analysis following outlook re...

Our credit view of this issuer reflects its solid prescription drug fundamentals, offset by its execution risk related to expansion into primary care.

Moody's Ratings affirms CVS's Baa2/P-2 ratings; revises outlook to neg...

Moody's Ratings (Moody's) affirmed the ratings of CVS Health Corporation ("CVS") including the Baa2 senior unsecured notes, (P)Baa2 senior unsecured shelf and Prime-2 senior unsecured commercial paper rating. At the same time, we revised CVS's outlook to negative from stable. The affirmation of th...

 PRESS RELEASE

EQS-News: Alles auf Rot - Aus „antwerpes“ wird 'DocCheck Agency“

EQS-News: DocCheck AG / Schlagwort(e): Sonstiges Alles auf Rot - Aus „antwerpes“ wird 'DocCheck Agency“ 17.07.2024 / 10:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die DocCheck AG plant die Umbenennung der antwerpes Agenturgruppe. Sie soll zum 4. Quartal 2024 erfolgen. „Wir werden im Healthcare-Markt künftig nur noch mit einer Marke auftreten. Und die ist rot.“ so Dr. Frank Antwerpes, CEO der DocCheck AG.  Die Agenturgruppe bleibt unter der neuen Firmierung als eigenständige Einheit bestehen. Parallel zur Umbenennung wird die k...

Moody's Ratings assigns Baa2 rating to CVS's sr. unsecured notes; outl...

Moody's Ratings (Moody's) assigned a Baa2 rating to the new senior unsecured notes issuance of CVS Health Corporation ("CVS"). There are no changes to CVS's existing ratings including the Baa2 senior unsecured long-term rating or the Prime-2 commercial paper rating. The outlook remains unchanged at ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch